rOmpF and OMVs as efficient subunit vaccines against Salmonella enterica serovar Enteritidis infections in poultry farms

Qiuchun Li,Jingwei Ren,Honghong Xian,Chao Yin,Yu Yuan,Yang Li,Ruoyun Ji,Chao Chu,Zhuang Qiao,Xinan Jiao
DOI: https://doi.org/10.1016/j.vaccine.2020.08.074
IF: 4.169
2020-10-01
Vaccine
Abstract:<p><em>Salmonella enterica</em> serovar Enteritidis remains the most prevalent serotype causing human salmonellosis through the consumption of contaminated foods, especially poultry products. The development of a subunit vaccine against <em>S.</em> Enteritidis can not only protect chickens against <em>Salmonella</em> infection in the poultry industry but also cut the transmission sources. In this study, both the expressed recombinant outer membrane protein F (rOmpF) and extracted outer membrane vesicles (OMVs) were developed as subunit vaccines against <em>S.</em> Enteritidis challenge in chickens. Immunization with the subunit vaccine could induce not only antibody production but also strong cell-mediated immune response. Both rOmpF plus QuilA adjuvant and OMVs alone had highly protective efficacy against <em>S.</em> Enteritidis challenge and rapidly decreased the colonization of bacteria in chicken. These findings revealed the potential application of rOmpF and OMVs as subunit vaccines in the poultry industry.</p>
immunology,medicine, research & experimental
What problem does this paper attempt to address?